BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21153565)

  • 1. Mutation analysis of the PALB2 cancer predisposition gene in familial melanoma.
    Sabbaghian N; Kyle R; Hao A; Hogg D; Tischkowitz M
    Fam Cancer; 2011 Jun; 10(2):315-7. PubMed ID: 21153565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of PALB2 as a candidate melanoma susceptibility gene.
    Aoude LG; Xu M; Zhao ZZ; Kovacs M; Palmer JM; Johansson P; Symmons J; Trent JM; Martin NG; Montgomery GW; Brown KM; Hayward NK
    PLoS One; 2014; 9(6):e100683. PubMed ID: 24949998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer.
    Tischkowitz M; Sabbaghian N; Ray AM; Lange EM; Foulkes WD; Cooney KA
    Prostate; 2008 May; 68(6):675-8. PubMed ID: 18288683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
    Zhen DB; Rabe KG; Gallinger S; Syngal S; Schwartz AG; Goggins MG; Hruban RH; Cote ML; McWilliams RR; Roberts NJ; Cannon-Albright LA; Li D; Moyes K; Wenstrup RJ; Hartman AR; Seminara D; Klein AP; Petersen GM
    Genet Med; 2015 Jul; 17(7):569-77. PubMed ID: 25356972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel germline PALB2 truncating mutations in African American breast cancer patients.
    Zheng Y; Zhang J; Niu Q; Huo D; Olopade OI
    Cancer; 2012 Mar; 118(5):1362-70. PubMed ID: 21932393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer.
    Yang XR; Jessop L; Myers T; Amundadottir L; Pfeiffer RM; Wheeler W; Pike KM; Yuenger J; Burdett L; Yeager M; Chanock SJ; Tucker MA; Goldstein AM
    Fam Cancer; 2011 Sep; 10(3):545-8. PubMed ID: 21614589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline mutations of PALB2 gene in a sequential series of Chinese patients with breast cancer.
    Zhang K; Zhou J; Zhu X; Luo M; Xu C; Yu J; Deng M; Zheng S; Chen Y
    Breast Cancer Res Treat; 2017 Dec; 166(3):865-873. PubMed ID: 28825143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
    Rahman N; Seal S; Thompson D; Kelly P; Renwick A; Elliott A; Reid S; Spanova K; Barfoot R; Chagtai T; Jayatilake H; McGuffog L; Hanks S; Evans DG; Eccles D; ; Easton DF; Stratton MR
    Nat Genet; 2007 Feb; 39(2):165-7. PubMed ID: 17200668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families.
    Teo ZL; Park DJ; Provenzano E; Chatfield CA; Odefrey FA; Nguyen-Dumont T; ; Dowty JG; Hopper JL; Winship I; Goldgar DE; Southey MC
    Breast Cancer Res; 2013 Feb; 15(1):R17. PubMed ID: 23448497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of PALB2 gene in French breast cancer families.
    Damiola F; Schultz I; Barjhoux L; Sornin V; Dondon MG; Eon-Marchais S; Marcou M; ; Caron O; Gauthier-Villars M; de Pauw A; Luporsi E; Berthet P; Delnatte C; Bonadona V; Maugard C; Pujol P; Lasset C; Longy M; Bignon YJ; Fricker JP; Andrieu N; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Muller D
    Breast Cancer Res Treat; 2015 Dec; 154(3):463-71. PubMed ID: 26564480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of PALB2/FANCN-associated breast cancer families.
    Tischkowitz M; Xia B; Sabbaghian N; Reis-Filho JS; Hamel N; Li G; van Beers EH; Li L; Khalil T; Quenneville LA; Omeroglu A; Poll A; Lepage P; Wong N; Nederlof PM; Ashworth A; Tonin PN; Narod SA; Livingston DM; Foulkes WD
    Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6788-93. PubMed ID: 17420451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PALB2 mutations in familial breast and pancreatic cancer.
    Hofstatter EW; Domchek SM; Miron A; Garber J; Wang M; Componeschi K; Boghossian L; Miron PL; Nathanson KL; Tung N
    Fam Cancer; 2011 Jun; 10(2):225-31. PubMed ID: 21365267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel germline PALB2 deletion in Polish breast and ovarian cancer patients.
    Dansonka-Mieszkowska A; Kluska A; Moes J; Dabrowska M; Nowakowska D; Niwinska A; Derlatka P; Cendrowski K; Kupryjanczyk J
    BMC Med Genet; 2010 Feb; 11():20. PubMed ID: 20122277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PALB2 sequence variants in young South African breast cancer patients.
    Sluiter M; Mew S; van Rensburg EJ
    Fam Cancer; 2009; 8(4):347-53. PubMed ID: 19333784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.
    Jones S; Hruban RH; Kamiyama M; Borges M; Zhang X; Parsons DW; Lin JC; Palmisano E; Brune K; Jaffee EM; Iacobuzio-Donahue CA; Maitra A; Parmigiani G; Kern SE; Velculescu VE; Kinzler KW; Vogelstein B; Eshleman JR; Goggins M; Klein AP
    Science; 2009 Apr; 324(5924):217. PubMed ID: 19264984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.
    Casadei S; Norquist BM; Walsh T; Stray S; Mandell JB; Lee MK; Stamatoyannopoulos JA; King MC
    Cancer Res; 2011 Mar; 71(6):2222-9. PubMed ID: 21285249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A PALB2 germline mutation associated with hereditary breast cancer in Italy.
    Papi L; Putignano AL; Congregati C; Piaceri I; Zanna I; Sera F; Morrone D; Genuardi M; Palli D
    Fam Cancer; 2010 Jun; 9(2):181-5. PubMed ID: 19763884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women.
    Foulkes WD; Ghadirian P; Akbari MR; Hamel N; Giroux S; Sabbaghian N; Darnel A; Royer R; Poll A; Fafard E; Robidoux A; Martin G; Bismar TA; Tischkowitz M; Rousseau F; Narod SA
    Breast Cancer Res; 2007; 9(6):R83. PubMed ID: 18053174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer.
    Hellebrand H; Sutter C; Honisch E; Gross E; Wappenschmidt B; Schem C; Deissler H; Ditsch N; Gress V; Kiechle M; Bartram CR; Schmutzler RK; Niederacher D; Arnold N; Meindl A
    Hum Mutat; 2011 Jun; 32(6):E2176-88. PubMed ID: 21618343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast-cancer risk in families with mutations in PALB2.
    Antoniou AC; Casadei S; Heikkinen T; Barrowdale D; Pylkäs K; Roberts J; Lee A; Subramanian D; De Leeneer K; Fostira F; Tomiak E; Neuhausen SL; Teo ZL; Khan S; Aittomäki K; Moilanen JS; Turnbull C; Seal S; Mannermaa A; Kallioniemi A; Lindeman GJ; Buys SS; Andrulis IL; Radice P; Tondini C; Manoukian S; Toland AE; Miron P; Weitzel JN; Domchek SM; Poppe B; Claes KB; Yannoukakos D; Concannon P; Bernstein JL; James PA; Easton DF; Goldgar DE; Hopper JL; Rahman N; Peterlongo P; Nevanlinna H; King MC; Couch FJ; Southey MC; Winqvist R; Foulkes WD; Tischkowitz M
    N Engl J Med; 2014 Aug; 371(6):497-506. PubMed ID: 25099575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.